Stephens Boosts Azenta Price Target to 55.00
AZTA Stock | USD 45.94 0.03 0.07% |
About 61% of Azenta's investor base is looking to short. The analysis of overall sentiment of trading Azenta Inc stock suggests that many investors are alarmed at this time. The current market sentiment, together with Azenta's historical and current headlines, can help investors time the market. In addition, many technical investors use Azenta Inc stock news signals to limit their universe of possible portfolio assets.
Azenta |
Azenta had its price objective raised by analysts at Stephens from 45.00 to 55.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. Stephens target price would indicate a potential downside of 3.51 percent from the companys current price. Several other equities analysts have also weighed in
Read at thelincolnianonline.com
Azenta Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Azenta can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Azenta Fundamental Analysis
We analyze Azenta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Azenta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Azenta based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Azenta is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Azenta Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Azenta stock to make a market-neutral strategy. Peer analysis of Azenta could also be used in its relative valuation, which is a method of valuing Azenta by comparing valuation metrics with similar companies.
Peers
Azenta Related Equities
AKYA | Akoya Biosciences | 3.83 | ||||
BDX | Becton Dickinson | 2.77 | ||||
BLCO | Bausch Lomb | 2.53 | ||||
ANGO | AngioDynamics | 0.55 | ||||
ATR | AptarGroup | 0.39 | ||||
ICUI | ICU Medical | 0.46 | ||||
HOLX | Hologic | 0.58 | ||||
MMSI | Merit Medical | 0.73 | ||||
NVST | Envista Holdings | 0.93 | ||||
HAE | Haemonetics | 1.25 | ||||
COO | Cooper Companies, | 2.61 | ||||
ATRC | AtriCure | 3.50 |
Complementary Tools for Azenta Stock analysis
When running Azenta's price analysis, check to measure Azenta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Azenta is operating at the current time. Most of Azenta's value examination focuses on studying past and present price action to predict the probability of Azenta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Azenta's price. Additionally, you may evaluate how the addition of Azenta to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |